Skip to main content
Clinical Trials/ACTRN12612000544875
ACTRN12612000544875
Recruiting
未知

Pharmacokinetics, pharmacodynamics and pharmacogenomics of busulphan and other agents used in blood or marrow transplantation

The Children's Hospital at Westmead0 sites300 target enrollmentMay 22, 2012

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
The Children's Hospital at Westmead
Enrollment
300
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 22, 2012
End Date
TBD
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
The Children's Hospital at Westmead

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients of any age receiving IV busulphan and /or other conditioning agents prior to autologous or allogeneic transplantation to treat both malignant and non\-malignant disease.
  • 2\. Patients require adequate venous access preferably with a central venous catheter but will be as per institution’s transplant policy
  • 3\.Written informed consent

Exclusion Criteria

  • Those for whom written informed consent cannot be obtained.

Outcomes

Primary Outcomes

Not specified

Similar Trials